Edward joined Amadeus in 2020 focusing on European deeptech companies.
Edward was previously at M Ventures, the €400m AUM corporate VC-arm of Merck KGaA, where he was responsible for health-tech, frontier-tech and sustainability investments. Edward led, among others, the investments in Akili Interactive Labs (the first-ever FDA-approved prescription video-game); Wiliot (battery-free Bluetooth tags with infinite lifetime, enabling a true connected-everything), and Sonde Health (voice-analysis platform for health and wellness inferences for use on self-owned devices).
Prior to M Ventures, Edward was in the Life Sciences securities team at Kempen & Co, a pan-European merchant bank, covering listed small- and mid-cap Life Sciences equities. He started his career as an analyst within the biopharma investment team of M Ventures.
Edward holds an MSc in Biopharmaceutical Sciences from Leiden University, the Netherlands, with a specialisation in pharmacology.